Brought to you by 
Illumina buys BlueGnome
27 Sep 2012
Executive Summary
Illumina Inc. has acquired BlueGnome Ltd., a privately held company focused on diagnostics for genetic abnormalities associated with developmental delay, cancer, and infertility.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Cytology
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com